X

finanzen.net ZERO schenkt Dir bis zu 300 € Wechselprämie!

Wechsle jetzt zum mehrfachen 'Kostensieger' der Stiftung Warentest (12/2025) und hol' Dir Deinen Neukundenbonus.
Es gelten die Aktionsfristen und Teilnahmebedingungen.

Jetzt informieren

Nicht mehr anzeigen

Fulcrum Therapeutics Aktie

Kaufen

Verkaufen

9,65 USD +1,01 USD +11,69 %

17.11.2025

BTT

Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Bei einem anderen Broker handeln

Smartphone

Marktkap.403,38 Mio. EUR

Div. Rendite0,00%

WKNA2PM28

ISINUS3596161097

SymbolFULC

Fulcrum Therapeutics Aktien News

Sortieren:Datum Meistgelesen

23.09.24PR NewswireFULC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Fulcrum Therapeutics, Inc. and Encourages Investors to Contact the Firm!

15.09.24PR NewswireFULC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Fulcrum Therapeutics, Inc. and Encourages Investors to Contact the Firm!

24.06.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulcrum Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FULC

20.06.23PR NewswireFULC Investors Have Opportunity to Lead Fulcrum Therapeutics, Inc. Securities Fraud Lawsuit

14.06.23PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fulcrum Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 27, 2023 - (NASDAQ: FULC)

13.06.23PR NewswireROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FULC

03.06.23PR NewswireFULC INVESTOR NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FULC

30.05.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulcrum Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FULC

27.05.23PR NewswireROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FULC

23.05.23PR NewswireFULC ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 27, 2023 in the Class Action Filed on Behalf of Fulcrum Therapeutics, Inc. Shareholders

21.05.23PR NewswireROSEN, RESPECTED INVESTOR COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FULC

19.05.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulcrum Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FULC

18.05.23PR NewswireFULC LAWSUIT ALERT: Levi & Korsinsky Notifies Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

11.05.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulcrum Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FULC

09.05.23PR NewswireFULC ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 27, 2023 in the Class Action Filed on Behalf of Fulcrum Therapeutics, Inc. Shareholders

02.05.23PR NewswireInvestor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fulcrum Therapeutics, Inc. (FULC) Investors of Class Action and to Actively Participate

23.03.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulcrum Therapeutics, Inc. - FULC

13.03.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulcrum Therapeutics, Inc. - FULC

04.03.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulcrum Therapeutics, Inc. - FULC

Fulcrum Therapeutics News

Fulcrum Therapeutics News: auf dieser Seite finden Sie alle Fulcrum Therapeutics News und Nachrichten zur Fulcrum Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Fulcrum Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Fulcrum Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.